LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 46 filers reported holding LYRA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $864 | +76.7% | 221 | +85.7% | 0.00% | – |
| Q2 2023 | $489 | +113.5% | 119 | +4.4% | 0.00% | – |
| Q1 2023 | $229 | -35.5% | 114 | +0.9% | 0.00% | – |
| Q4 2022 | $355 | -64.5% | 113 | +2.7% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 110 | -0.9% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 111 | -79.3% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 537 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -60.0% | 537 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +25.0% | 537 | +2.7% | 0.00% | – |
| Q2 2021 | $4,000 | -83.3% | 523 | -74.9% | 0.00% | – |
| Q1 2021 | $24,000 | -40.0% | 2,085 | -40.8% | 0.00% | – |
| Q4 2020 | $40,000 | +233.3% | 3,521 | +225.1% | 0.00% | – |
| Q3 2020 | $12,000 | -50.0% | 1,083 | -48.0% | 0.00% | – |
| Q2 2020 | $24,000 | – | 2,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,550,000 | 16.38% |
| Soleus Capital Management, L.P. | 456,138 | $5,199,000 | 0.69% |
| Ikarian Capital, LLC | 815,364 | $9,295,000 | 0.41% |
| Perceptive Advisors | 3,222,561 | $36,737,000 | 0.39% |
| Affinity Asset Advisors, LLC | 50,000 | $570,000 | 0.30% |
| RA Capital Management | 815,849 | $9,301,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 775,888 | $8,845,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 87,353 | $996,000 | 0.04% |
| Altium Capital Management LP | 5,218 | $59,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,000 | $559,000 | 0.01% |